Tralokinumab Real-World Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis Adult Patients in the United States: 6-Month Interim Analysis. J of Skin [Internet]. 2024 Jan. 16 [cited 2025 Apr. 3];8(1):s318. Available from: https://skin.dermsquared.com/skin/article/view/2399